Literature DB >> 10883665

Epithelial cells in bone marrow of oesophageal cancer patients: a significant prognostic factor in multivariate analysis.

S Thorban1, R Rosenberg, R Busch, R J Roder.   

Abstract

The detection of epithelial cells in bone marrow, blood or lymph nodes indicates a disseminatory potential of solid tumours. 225 patients with squamous cell carcinoma of the oesophagus were prospectively studied. Prior to any therapy, cytokeratin-positive (CK) cells in bone marrow were immunocytochemically detected in 75 patients with the monoclonal anti-epithelial-cell antibody A45-B/B3 and correlated with established histopathologic and patient-specific prognosis factors. The prognosis factors were assessed by multivariate analysis. Twenty-nine of 75 (38.7%) patients with oesophageal cancer showed CK-positive cells in bone marrow. The analyses of the mean and median overall survival time showed a significant difference between patients with and without epithelial cells in bone marrow (P < 0.001). Multivariate analysis in the total patient population and in patients with curative resection of the primary tumour confirmed the curative resection rate and the bone marrow status as the strongest independent prognostic factors, besides the T-category. The detection of epithelial cells in bone marrow of oesophageal cancer patients is a substantial prognostic factor proved by multivariate analysis and is helpful for exact preoperative staging, as well as monitoring of neoadjuvant therapy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10883665      PMCID: PMC2374527          DOI: 10.1054/bjoc.2000.1199

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  24 in total

1.  Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.

Authors:  I J Diel; M Kaufmann; S D Costa; R Holle; G von Minckwitz; E F Solomayer; S Kaul; G Bastert
Journal:  J Natl Cancer Inst       Date:  1996-11-20       Impact factor: 13.506

2.  Meta-analyses of studies on bone marrow micrometastases: an independent prognostic impact remains to be substantiated.

Authors:  I Funke; W Schraut
Journal:  J Clin Oncol       Date:  1998-02       Impact factor: 44.544

3.  Pattern of recurrence after oesophageal resection for cancer: clinical implications.

Authors:  S Y Law; M Fok; J Wong
Journal:  Br J Surg       Date:  1996-01       Impact factor: 6.939

4.  The prognostic significance of lymph node micrometastasis in patients with esophageal carcinoma.

Authors:  J N Glickman; C Torres; H H Wang; J R Turner; A Shahsafaei; W G Richards; D J Sugarbaker; R D Odze
Journal:  Cancer       Date:  1999-02-15       Impact factor: 6.860

5.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

6.  Micrometastases in esophagogastric cancer: high detection rate in resected rib segments.

Authors:  G C O'sullivan; D Sheehan; A Clarke; R Stuart; J Kelly; M D Kiely; T Walsh; J K Collins; F Shanahan
Journal:  Gastroenterology       Date:  1999-03       Impact factor: 22.682

7.  Role of endoscopic ultrasonography in esophageal carcinoma.

Authors:  H J Dittler; J R Siewert
Journal:  Endoscopy       Date:  1993-02       Impact factor: 10.093

Review 8.  Multimodal treatment for squamous cell esophageal cancer.

Authors:  U Fink; H J Stein; H Wilke; J D Roder; J R Siewert
Journal:  World J Surg       Date:  1995 Mar-Apr       Impact factor: 3.352

9.  Survival of patients with carcinoma of the esophagus treated with combined-modality therapy.

Authors:  W G Wolfe; A L Vaughn; H F Seigler; J W Hathorn; K A Leopold; F G Duhaylongsod
Journal:  J Thorac Cardiovasc Surg       Date:  1993-04       Impact factor: 5.209

Review 10.  Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers.

Authors:  G Riethmüller; J P Johnson
Journal:  Curr Opin Immunol       Date:  1992-10       Impact factor: 7.486

View more
  9 in total

Review 1.  [Minimal residual tumor in gastrointestinal carcinoma. Relevance to prognosis and oncologic surgical consequences].

Authors:  S Gretschel; A Bembenek; T Schulze; W Kemmner; P M Schlag
Journal:  Chirurg       Date:  2006-12       Impact factor: 0.955

2.  Prognostic impact of CK-20-positive cells in peripheral venous blood of patients with gastrointestinal carcinoma.

Authors:  Jan Friederichs; Ralf Gertler; Robert Rosenberg; Jörg Nahrig; Katrin Führer; Bernhard Holzmann; Hans-Joachim Dittler; Michael Dahm; Stefan Thorban; Hjalmar Nekarda; Jörg Rüdiger Siewert
Journal:  World J Surg       Date:  2005-04       Impact factor: 3.352

Review 3.  The Relationship Between Dormant Cancer Cells and Their Microenvironment.

Authors:  N Linde; G Fluegen; J A Aguirre-Ghiso
Journal:  Adv Cancer Res       Date:  2016-08-25       Impact factor: 6.242

4.  Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.

Authors:  Ines Gockel; Carl C Schimanski; Christian Heinrich; T Wehler; K Frerichs; Daniel Drescher; Christian von Langsdorff; Mario Domeyer; Stefan Biesterfeld; Peter R Galle; Theodor Junginger; Markus Moehler
Journal:  BMC Cancer       Date:  2006-12-18       Impact factor: 4.430

5.  Hamburg-Glasgow classification: preoperative staging by combination of disseminated tumour load and systemic inflammation in oesophageal carcinoma.

Authors:  Matthias Reeh; Tarik Ghadban; Faik G Uzunoglu; Michael F Nentwich; Maximilian Bockhorn; Klaus Pantel; Jakob R Izbicki; Yogesh K Vashist
Journal:  Br J Cancer       Date:  2017-07-13       Impact factor: 7.640

6.  Correlation of CK-20-positive cells in peripheral venous blood with serum CEA levels in patients with colorectal carcinoma.

Authors:  Jan Friederichs; Ralf Gertler; Robert Rosenberg; Michael Dahm; Hjalmar Nekarda; Bernhard Holzmann; Jörg Rüdiger Siewert
Journal:  World J Surg       Date:  2007-12       Impact factor: 3.282

7.  Redistribution of β-catenin in response to EGF and lithium signalling in human oesophageal squamous carcinoma cell lines.

Authors:  Lindsay Jg Jones; Rob B Veale
Journal:  Cancer Cell Int       Date:  2003-08-15       Impact factor: 5.722

8.  Prognostic significance of prospectively detected bone marrow micrometastases in esophagogastric cancer: 10-year follow-up confirms prognostic significance.

Authors:  Paul Ryan; Heidi Furlong; Conleth G Murphy; Finbarr O'Sullivan; Thomas N Walsh; Fergus Shanahan; Gerald C O'Sullivan
Journal:  Cancer Med       Date:  2015-04-27       Impact factor: 4.452

9.  Lymph Node and Bone Marrow Micrometastases Define the Prognosis of Patients with pN0 Esophageal Cancer.

Authors:  Karl-F Karstens; Tarik Ghadban; Katharina Effenberger; Guido Sauter; Klaus Pantel; Jakob R Izbicki; Yogesh Vashist; Alexandra König; Matthias Reeh
Journal:  Cancers (Basel)       Date:  2020-03-04       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.